These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12661064)

  • 1. Timed-release formulation to avoid drug-drug interaction between diltiazem and midazolam.
    Sawada T; Sako K; Yoshihara K; Nakamura K; Yokohama S; Hayashi M
    J Pharm Sci; 2003 Apr; 92(4):790-7. PubMed ID: 12661064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro and in-vivo characteristics of a modified-release double-pulse formulation for a water soluble drug.
    Avramoff A; Domb AJ
    Int J Clin Pharmacol Ther; 2010 Apr; 48(4):250-8. PubMed ID: 20353746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation.
    Scheiwe MW; Lankhaar G; Kleinbloesem CH
    Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Cho YA; Choi DH; Choi JS
    J Pharm Pharmacol; 2009 Jun; 61(6):825-9. PubMed ID: 19505375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bioavailability of diltiazem in prolonged-release oral preparations.
    Quiroga PA; Yuln GV; Palummo M; Cingolani A; Dall LL; Volonté MG
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1099-106. PubMed ID: 11794812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
    Korhonen O; Kanerva H; Vidgren M; Urtti A; Ketolainen J
    J Control Release; 2004 Mar; 95(3):515-20. PubMed ID: 15023462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on pulsatile release tablets of diltiazem hydrochloride in explosion way].
    Fan TY; Wei SL; Yan WW; Ding WX
    Yao Xue Xue Bao; 2002 Mar; 37(3):221-5. PubMed ID: 12579768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetic profiles of amlodipine and of a sustained release form of diltiazem.
    Fourtillan JB; Ingrand I; Decourt JP; Istin B; Girault J
    Therapie; 1998; 53(2):121-6. PubMed ID: 9773111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro-in vivo evaluation of a multiparticulate sustained release formulation of diltiazem.
    Li SP; Felt RG; Di Paolo LC; Huang MY; Williams RO
    Pharm Res; 1995 Sep; 12(9):1338-42. PubMed ID: 8570532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of a novel diltiazem hydrochloride polydispersity sustained-release system.
    Sun C; Liu H; Zhao X; He H; Pan W
    Drug Dev Ind Pharm; 2013 Jan; 39(1):62-6. PubMed ID: 22339081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.
    Choi JS; Li X
    Int J Pharm; 2005 Jun; 297(1-2):1-8. PubMed ID: 15907592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diltiazem on midazolam and alfentanil disposition in patients undergoing coronary artery bypass grafting.
    Ahonen J; Olkkola KT; Salmenperä M; Hynynen M; Neuvonen PJ
    Anesthesiology; 1996 Dec; 85(6):1246-52. PubMed ID: 8968170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different durations and formulations of diltiazem on the single-dose pharmacokinetics of midazolam: how long do we go?
    Friedman EJ; Fraser IP; Wang YH; Bergman AJ; Li CC; Larson PJ; Chodakewitz J; Wagner JA; Stoch SA
    J Clin Pharmacol; 2011 Nov; 51(11):1561-70. PubMed ID: 21209240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats.
    Hong SP; Choi DH; Choi JS
    Cardiovasc Ther; 2008; 26(4):269-75. PubMed ID: 19035878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers.
    Böttiger Y; Säwe J; Brattström C; Tollemar J; Burke JT; Häss G; Zimmerman JJ
    Clin Pharmacol Ther; 2001 Jan; 69(1):32-40. PubMed ID: 11180036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose of midazolam should be reduced during diltiazem and verapamil treatments.
    Backman JT; Olkkola KT; Aranko K; Himberg JJ; Neuvonen PJ
    Br J Clin Pharmacol; 1994 Mar; 37(3):221-5. PubMed ID: 8198928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of diltiazem in beagle dog from pulsatile release tablet.
    Ishino R; Yoshino H; Hirakawa Y; Noda K
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3094-6. PubMed ID: 1477926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.